Cargando…

Association of TM6SF2 rs58542926 T/C gene polymorphism with hepatocellular carcinoma: a meta-analysis

BACKGROUND: Hepatocellular carcinoma (HCC) is the sixth-most common malignancy worldwide. Multiple previous studies have assessed the relationship between TM6SF2 gene polymorphism and the risk of developing HCC, with discrepant conclusions reached. To assess the association of TM6SF2 rs58542926 T/C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Shan, Zhang, Jing, Mei, Ting-Ting, Guo, Hai-Qing, Wei, Xin-Huan, Zhang, Wen-Yan, Liu, Ya-Li, Liang, Shan, Fan, Zuo-Peng, Ma, Li-Xia, Lin, Wei, Liu, Yi-Rong, Qiu, Li-Xia, Yu, Hai-Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868855/ https://www.ncbi.nlm.nih.gov/pubmed/31752753 http://dx.doi.org/10.1186/s12885-019-6173-4

Ejemplares similares

TM6SF2 rs58542926 is related to hepatic steatosis, fibrosis and serum lipids both in adults and children: A meta-analysis
por: Li, Xue-Ying, et al.
Publicado: (2022)

Association of TM6SF2 rs58542926 gene polymorphism with the risk of non-alcoholic fatty liver disease and colorectal adenoma in Chinese Han population
por: Li, Yuan, et al.
Publicado: (2019)

Influence of Type 2 Diabetes in the Association of PNPLA3 rs738409 and TM6SF2 rs58542926 Polymorphisms in NASH Advanced Liver Fibrosis
por: Gabriel-Medina, Pablo, et al.
Publicado: (2022)

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
por: Liu, Yang-Lin, et al.
Publicado: (2014)

Association of PNPLA3 rs738409 and TM6SF2 rs58542926 with health services utilization in a population-based study
por: Köpp, Julia, et al.
Publicado: (2016)

TM6SF2-rs58542926 Genetic Variant Modifies the Protective Effect of a “Prudent” Dietary Pattern on Serum Triglyceride Levels
por: Kalafati, Ioanna Panagiota, et al.
Publicado: (2023)

Association of PNPLA3 (rs738409) & TM6SF2 (rs58542926) and ATG16L1 (rs2241880) genetic variants with susceptibility to hepatocellular carcinoma in a group of Egyptian patients with HCV-induced liver cirrhosis
por: Mohamed Fteah, Asmaa, et al.
Publicado: (2023)

Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis
por: Tang, Shan, et al.
Publicado: (2020)

The roles of transmembrane 6 superfamily member 2 rs58542926 polymorphism in chronic liver disease: A meta‐analysis of 24,147 subjects
por: Chen, Xinpei, et al.
Publicado: (2019)

NOTCH3 rs1043996 Polymorphism Is Associated with the Occurrence of Alcoholic Liver Cirrhosis Independently of PNPLA3 and TM6SF2 Polymorphisms
por: Bainrauch, Ana, et al.
Publicado: (2021)

TM4SF1, a binding protein of DVL2 in hepatocellular carcinoma, positively regulates beta‐catenin/TCF signalling
por: Zhu, ChuanrRong, et al.
Publicado: (2019)

Down-regulation of TM4SF is associated with the metastatic potential of gastric carcinoma TM4SF members in gastric carcinoma
por: Chen, Zhouxun, et al.
Publicado: (2011)

E167K polymorphism of TM6SF2 gene affects cell cycle of hepatocellular carcinoma cell HEPA 1-6
por: Du, Shuixian, et al.
Publicado: (2017)

Three Members of Transmembrane-4-Superfamily, TM4SF1, TM4SF4, and TM4SF5, as Emerging Anticancer Molecular Targets against Cancer Phenotypes and Chemoresistance
por: Rahim, Nur Syafiqah, et al.
Publicado: (2023)

Myeloid TM6SF2 Deficiency Inhibits Atherosclerosis
por: Zhu, Wenzhen, et al.
Publicado: (2022)

TM4SF1 upregulates MYH9 to activate the NOTCH pathway to promote cancer stemness and lenvatinib resistance in HCC
por: Yang, Si-bo, et al.
Publicado: (2023)

N-terminus-independent activation of c-Src via binding to a tetraspan(in) TM4SF5 in hepatocellular carcinoma is abolished by the TM4SF5 C-terminal peptide application
por: Song, Haeng Eun, et al.
Publicado: (2021)

The association of PTPN22 rs2476601 polymorphism and CTLA-4 rs231775 polymorphism with LADA risks: a systematic review and meta-analysis
por: Dong, Fang, et al.
Publicado: (2014)

PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease
por: Lisboa, Quelson Coelho, et al.
Publicado: (2020)

Targeting TM4SF5 with anti-TM4SF5 monoclonal antibody suppresses the growth and motility of human pancreatic cancer cells
por: Park, Sangkyu, et al.
Publicado: (2020)

TM9SF4 Is a Crucial Regulator of Inflammation and ER Stress in Inflammatory Bowel Disease
por: Xie, Mingxu, et al.
Publicado: (2022)

A Single Nucleotide Polymorphism rs1010816 Predicts Sorafenib Therapeutic Outcomes in Advanced Hepatocellular Carcinoma
por: Lin, Chih-Lang, et al.
Publicado: (2023)

Anti-cancer Activity of Novel TM4SF5-Targeting Antibodies through TM4SF5 Neutralization and Immune Cell-Mediated Cytotoxicity
por: Ahn, Hye-Mi, et al.
Publicado: (2017)

LINC01232 exerts oncogenic activities in pancreatic adenocarcinoma via regulation of TM9SF2
por: Li, Qian, et al.
Publicado: (2019)

Association of TFPI polymorphisms rs8176592, rs10931292, and rs10153820 with venous thrombosis: A meta-analysis
por: Zhang, Yunhong, et al.
Publicado: (2019)

Anesthesia and airway managements for emergency removal of esophageal foreign body in a trisomy 21 patient with mental retardation and predicted difficult airway: A case report
por: Wei, Wei, et al.
Publicado: (2020)

TM4SF10 gene sequencing in XLMR patients identifies common polymorphisms but no disease-associated mutation
por: Christophe-Hobertus, Christiane, et al.
Publicado: (2004)

Long Noncoding RNA BCYRN1 Recruits BATF to Promote TM4SF1 Upregulation and Enhance HCC Cell Proliferation and Invasion
por: Liu, Ya, et al.
Publicado: (2022)

TM4SF1 Promotes Proliferation, Invasion, and Metastasis in Human Liver Cancer Cells
por: Huang, Yu-Kun, et al.
Publicado: (2016)

Association between KIF1B (rs17401966) polymorphism and hepatocellular carcinoma susceptibility: a meta-analysis
por: Zhang, Ya-fei, et al.
Publicado: (2018)

The Association Between the rs2975760 and rs3792267 Single Nucleotide Polymorphisms of Calpain 10 (CAPN10) and Gestational Diabetes Mellitus
por: Zhang, Xia, et al.
Publicado: (2019)

TM4SF5-Mediated Roles in the Development of Fibrotic Phenotypes
por: Ryu, Jihye, et al.
Publicado: (2017)

TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo
por: Cao, Jia, et al.
Publicado: (2015)

Therapeutic effects of TM4SF5-targeting chimeric and humanized monoclonal antibodies in hepatocellular and colon cancer models
por: Ko, Dongjoon, et al.
Publicado: (2022)

The TM6SF2 variant as a risk factor for hepatocellular carcinoma development in chronic liver disease patients
por: Raia, Gamal Y. S., et al.
Publicado: (2022)

The Genetics of Clinical Liver Diseases: Insight into the TM6SF2 E167K Variant
por: Zhang, Xiaoyu, et al.
Publicado: (2018)

m(6)Am methyltransferase PCIF1 is essential for aggressiveness of gastric cancer cells by inhibiting TM9SF1 mRNA translation
por: Zhuo, Wei, et al.
Publicado: (2022)

TM4SF1 Promotes Metastasis of Pancreatic Cancer via Regulating the Expression of DDR1
por: Yang, Jia-chun, et al.
Publicado: (2017)

TM9SF4 is an F-actin disassembly factor that promotes tumor progression and metastasis
por: Meng, Zhaoyue, et al.
Publicado: (2022)

TM4SF1 is a potential target for anti-invasion and metastasis in ovarian cancer
por: Gao, Caiyun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5k4bm3ihuos5n8r2fallkevua5